Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Daito Chemix's Sloan Ratio for the quarter that ended in Mar. 2026 was 0.16%.
As of Mar. 2026, Daito Chemix has a Sloan Ratio of 0.16%, indicating the company is in the safe zone and there is no funny business with accruals.
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Daito Chemix has a Sloan Ratio of 0.16%, indicating the company is in the safe zone and there is no funny business with accruals.
Daito Chemix Sloan Ratio % Related Terms
Daito Chemix Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Daito Chemix's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Daito Chemix's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daito Chemix Sloan Ratio % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Daito Chemix's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Daito Chemix's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Daito Chemix's Sloan Ratio for the fiscal year that ended in Mar. 2026 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Daito Chemix's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 210 (Sep. 2025 ) + 581 (Mar. 2026 ) = 円791 Mil.
Daito Chemix's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 710 (Sep. 2025 ) + 1875 (Mar. 2026 ) = 円2,585 Mil.
Daito Chemix's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -828 (Sep. 2025 ) + -1011 (Mar. 2026 ) = 円-1,839 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daito Chemix (TSE:4366) has a Sloan Ratio % of 0.16% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Daito Chemix and its competitors.
Is Daito Chemix's Sloan Ratio % too high?
Daito Chemix's current Sloan Ratio % is 0.16%. Overall, Daito Chemix has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Daito Chemix's Sloan Ratio % compare to DOW?
Daito Chemix's Sloan Ratio % of 0.16% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Chemicals company?
A good Sloan Ratio % depends on the Chemicals industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Daito Chemix and its competitors. Daito Chemix's current Sloan Ratio % is 0.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Chemix stock overvalued right now?
Based on GuruFocus' analysis, Daito Chemix (TSE:4366) is currently considered Significantly Overvalued. The stock's GF Value™ is 円259.45, compared to a current price of 円427.00 — trading 64.6% above its estimated fair value. The current Sloan Ratio % is 0.16%. Daito Chemix's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Daito Chemix (TSE:4366), the current Sloan Ratio % is 0.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daito Chemix (TSE:4366) Overvalued in 2026?
Based on GuruFocus' analysis, Daito Chemix stock appears to be overvalued.
The current stock price of 円427.00 is trading 64.6% above its estimated GF Value™ of 円259.45.
GuruFocus considers Daito Chemix to be Significantly Overvalued.
Key valuation signals for TSE:4366:
Sloan Ratio %: 0.16%
GF Value™: 円259.45 vs. price of 円427.00 (64.6% above fair value)
No single metric tells the full story. See the TSE:4366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daito Chemix Corporation is engaged in the manufacture and sale of photosensitive materials, printing materials, photography materials, recording materials, and pharmaceutical intermediates, as well as other chemical products in Japan.
66GF Score
Get the complete analysis for TSE:4366
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4366 has been successfully added to your 
